Form D · Other Health Care

NXT BIOMEDICAL, LLC

Irvine, CA · CIK 0001862731

Offering snapshot reported May 25, 2021 · SEC filing

Reported sold
$9.4M
Offering amount: $9.4M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 13, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$4.7M$9.4MMay 25, 2021: $6,000,000.00May 25, 2021May 25, 2021: $9,400,000.00May 25, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$6,000,000 → $9,400,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 25, 2021Initial$6,000,000No comparisonNot reportedSEC filing
May 25, 2021Amendment$9,400,000$3,400,000vs May 25, 20212SEC filing
May 25, 2021Initial$10,000,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-400576

Source: Form D, filed May 25, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Don Bobo Director
Andrew Cleeland Director
Andrew El Bardissi Director
Steven Hochberg Director
Kadhiresan V Kadir Director
Stanton Rowe Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
5171 California Avenue, Suite 150
Irvine, CA, 92617